| Type : |
Journal |
|
| forskerhold : |
Indianapolis - Eli Lilly and Company, Lilly Research Laboratories |
| Forfattere : |
Bornstein M, Lo AY, Thomas PN, Wilham WL. |
| Titel : |
Moxalactam disodium compatibility with intramuscular and intravenous diluents. |
| Nummer : |
Am J Hosp Pharm ; 39: 1495-1498. 1982 |
|
| cotationvaleur : |
|
| fysisk stabilitet : |
|
| kemisk stabilitet : |
|
| andre metoder : |
|
| Kommentarer : |
|
Lister
 Lidocaine hydrochloride
|
 |
|
|
Moxalactam
|
 |
 |
 |
 |
20 & 333 mg/ml |
25°C |
 |
| 24 |
 |
|
|
|
|
|
20 & 333 mg/ml |
5°C |
 |
| 96 |
|
|
|
|
|
 |
2 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
2 mg/ml |
5°C |
|
| 96 |
|
|
|
|
|
 |
20 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
20 mg/ml |
5°C |
|
| 96 |
|
|
|
|
|
 |
20 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
20 mg/ml |
5°C |
|
| 96 |
|
|
|
|
|
 |
20 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
20 mg/ml |
5°C |
|
| 96 |
|
|
|
|
|
 |
333 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
333 mg/ml |
5°C |
|
| 24 |
|
|
|
|
|
 |
333 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
333 mg/ml |
5°C |
|
| 96 |
|
|
|
|
|
 |
20 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
20 mg/ml |
5°C |
|
| 96 |
|
|
|
|
 |
|
20 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
20 mg/ml |
5°C |
|
| 96 |
|
|
|
|
333 mg/ml |
+ Lidocaine hydrochloride
|
5 & 10 mg/ml |
+
|
 |
|
|
